13/10 - DeepTech SD Valencia
The largest DeepTech Startups newsletter in the world (+300 cities)

Hola Terreta, hola, Valencia! We hope you’re having an excellent start of the week!

"En el núcleo del DeepTech, florece la innovación que redefine nuestro mundo. Es el punto donde la ciencia se une con el coraje para enfrentar los mayores retos de la humanidad. Construyamos juntos el futuro, transformando posibilidades en realidades, un descubrimiento a la vez."

"At the heart of DeepTech, innovation thrives to redefine our world. It is where science meets courage to tackle humanity's greatest challenges. Together, let’s build the future, turning possibilities into realities, one discovery at a time."

The largest Startup and Deeptech companies newsletter in the world (+300 cities)

TakeAways

Inflammatory dietary habits linked to 84% higher risk of dementia

Dementia is projected to reach 152 million cases by 2050, according to the World Health Organization, placing an increasing strain on caregivers and health care systems. While advancements in drug therapies have improved care and targeted disease mechanisms, preventive measures remain elusive.

Read more

Cognitive flexibility: How neural variability shapes decision-making in different brains

Cognitive flexibility is the ability of a brain to adapt its response to the same external stimulus, like light or sound, based on different contexts. For example, if someone calls your name in a crowded room, you must focus on the sound's location or the voice characteristics to identify the person. This flexibility in selecting and processing relevant information while ignoring irrelevant information is crucial for survival and effective interaction with our environment.

Read more

News

Santander to launch crypto trading via Openbank in Spain

The launch comes as European banks increasingly move to integrate digital assets into their core offerings.

Read more

Choice and SilMach unveil world’s first wireless micromotor-powered contraceptive implant

Choice and SilMach have developed a wireless microvalve implant that blocks or unblocks the fallopian tubes, offering a pain-free, reversible, hormone-free alternative to the pill and IUD.

Read more

Funding/M&A News

Promotion from TechCrunch

Meet leaders seeking a product like yours and investors looking to fund at TechCrunch Disrupt 2025

Take your startup to the next level alongside 10,000 founders and investors this October 27–29 in San Francisco. Learn from 250+ leading voices across 200+ sessions on five industry stages, breakouts, and roundtables built to fuel your growth. Register before doors open to save up to $444. Register Now

Barcelona-based 011h raises €20 million to accelerate low-carbon, tech-driven construction

Barcelona-based construction technology company 011h has raised €20 million in a new funding round led by Ship2B Ventures and CDTI (Centro para el Desarrollo Tecnológico y la Innovación).

Read more

Italy bets €100M on space smart factory to boost Europe’s satellite game

By the end of this year, Italy is set to open one of Europe’s largest and most advanced satellite manufacturing centres on the outskirts of Rome.

Read more

Startup in spotlight: Owlstone Medical scores $49.1M grant to create at-home multi-cancer detection

Cambridge-headquartered Owlstone Medical, co-founded by Billy Boyle, David Ruiz-Alonso, and Andrew Koehl in 2004 as a spin-out from the University of Cambridge’s Engineering Department, has been awarded up to $49.1 million from the U.S. Advanced Research Projects Agency for Health (ARPA-H).

Read more

Edinburgh’s Trogenix banks €80M to fuel ‘Trojan Horse’ cancer therapies

Scottish biotech company Trogenix has raised €80 million in Series A funding to accelerate its pipeline of next-generation cancer therapies targeting aggressive solid tumours.

Read more

Phagos bags €25M to combat antibiotic resistance with AI and personalised phage therapy

French biotech startup Phagos has raised €25 million in a Series A funding round co-led by CapAgro, Hoxton Ventures, CapHorn, and Demeter, with additional support from Acurio Ventures, Citizen Capital, Entrepreneur First, Founders Capital, and Station F.

Read more

Lauxera Capital closes €400M health tech fund, bets big on European innovation going global

Lauxera Capital Partners, with offices in Paris and San Francisco, has completed fundraising for its second Healthtech growth fund, surpassing €400 million and reaching its target in record time.

Read more